Torsdag 9 Oktober | 02:46:19 Europe / Stockholm

Prenumeration

2025-10-06 10:56:00

Redeye somewhat reduces its forecasts and Base Case in Transtema following lowered expectations on the Norwegian market. On the other hand, the share is trading close to its 3-year low despite the solid growth momentum in Sweden.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/